tiprankstipranks

Mark Lackner Insider Profile

4 Followers
Mark Lackner, SVP, Head of Biology at IDEAYA Biosciences, holds 191.32K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds 0.00 shares in IDEAYA Biosciences (Ticker: IDYA). Most recently, Mark Lackner Sold ― shares of Zentalis Pharmaceuticals on Jan 03, 2025 for an estimated value of 13.76K.
tipranks
Mark Lackner

Mark Lackner
IDEAYA Biosciences (IDYA)
SVP, Head of Biology

Ranked #31,458 out of 100,285 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+45.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$429K
100.00%
0.00%
A breakdown of Mark Lackner's holdings

Insider Roles

Zentalis Pharmaceuticals
(ZNTL)
CSO
IDEAYA Biosciences
(IDYA)
SVP, Head of Biology
Roles that Mark Lackner holds in companies

Most Profitable Insider Trade

Stock:
Zentalis Pharmaceuticals
(ZNTL)
Rating:Informative Sell
Date:Feb 05, 2024 - Today
Return:+75.70%
The most profitable trade made by Mark Lackner

Mark Lackner's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
IDEAYA Biosciences
Jan 28, 2021
SVP, Head of Biology
Uninformative Buy
9.58K
$0.00
Zentalis Pharmaceuticals
Jan 03, 2025
CSO
Informative Sell
13.76K
$428.55K
List of latest transactions for each holding click on a transaction to see Mark Lackner's performance on stock

Mark Lackner insider profile FAQ

What is the percentage of profitable transactions made by Mark Lackner?
The percentage of profitable transactions made by Mark Lackner is 100%.
    What is the average return per transaction made by Mark Lackner?
    The average return per transaction made by Mark Lackner is 45.40%.
      What stocks does Mark Lackner hold?
      Mark Lackner holds: IDYA, ZNTL stocks.
        What was Mark Lackner’s latest transaction?
        Mark Lackner latest transaction was an Informative Sell of $13.76K.
          What was Mark Lackner's most profitable transaction?
          Mark Lackner’s most profitable transaction was an Informative Sell of ZNTL stock on February 5, 2024. The return on the trade was 75.70%.
            What is Mark Lackner's role in IDEAYA Biosciences?
            Mark Lackner's role in IDEAYA Biosciences is SVP, Head of Biology.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.